123 related articles for article (PubMed ID: 15681897)
21. Diltiazem inhibition of cytochrome P-450 3A activity is due to metabolite intermediate complex formation.
Jones DR; Gorski JC; Hamman MA; Mayhew BS; Rider S; Hall SD
J Pharmacol Exp Ther; 1999 Sep; 290(3):1116-25. PubMed ID: 10454485
[TBL] [Abstract][Full Text] [Related]
22. Role of CYP3A4 in human hepatic diltiazem N-demethylation: inhibition of CYP3A4 activity by oxidized diltiazem metabolites.
Sutton D; Butler AM; Nadin L; Murray M
J Pharmacol Exp Ther; 1997 Jul; 282(1):294-300. PubMed ID: 9223567
[TBL] [Abstract][Full Text] [Related]
23. First-pass metabolism of gentisamide: influence of intestinal metabolism on hepatic formation of conjugates. Studies in the once-through vascularly perfused rat intestine-liver preparation.
Hirayama H; Pang KS
Drug Metab Dispos; 1990; 18(5):580-7. PubMed ID: 1981705
[TBL] [Abstract][Full Text] [Related]
24. Role of intestinal first-pass metabolism of baicalein in its absorption process.
Zhang L; Lin G; Chang Q; Zuo Z
Pharm Res; 2005 Jul; 22(7):1050-8. PubMed ID: 16028005
[TBL] [Abstract][Full Text] [Related]
25. In vitro-in vivo correlation of the effect of supersaturation on the intestinal absorption of BCS Class 2 drugs.
Higashino H; Hasegawa T; Yamamoto M; Matsui R; Masaoka Y; Kataoka M; Sakuma S; Yamashita S
Mol Pharm; 2014 Mar; 11(3):746-54. PubMed ID: 24460473
[TBL] [Abstract][Full Text] [Related]
26. Effects of ischemia-reperfusion on the absorption and esterase metabolism of diltiazem in rat intestine.
Molina AJ; Prieto JG; Merino G; Mendoza G; Real R; Pulido MM; Alvarez AI
Life Sci; 2007 Jan; 80(5):397-407. PubMed ID: 17070553
[TBL] [Abstract][Full Text] [Related]
27. Dose-dependent intestinal and hepatic first-pass metabolism of midazolam, a cytochrome P450 3A substrate with differently modulated enzyme activity in rats.
Higashikawa F; Murakami T; Kaneda T; Kato A; Takano M
J Pharm Pharmacol; 1999 Jan; 51(1):67-72. PubMed ID: 10197420
[TBL] [Abstract][Full Text] [Related]
28. [Effect of CYP3A and P-glycoprotein on the absorption of buagafuran in rat intestinal lumen].
Sheng L; Tan W; Hu JP; Chen H; Li Y
Yao Xue Xue Bao; 2010 Jan; 45(1):43-8. PubMed ID: 21351448
[TBL] [Abstract][Full Text] [Related]
29. In vivo modulation of intestinal CYP3A metabolism by P-glycoprotein: studies using the rat single-pass intestinal perfusion model.
Cummins CL; Salphati L; Reid MJ; Benet LZ
J Pharmacol Exp Ther; 2003 Apr; 305(1):306-14. PubMed ID: 12649383
[TBL] [Abstract][Full Text] [Related]
30. Utilizing in vitro and PBPK tools to link ADME characteristics to plasma profiles: case example nifedipine immediate release formulation.
Wagner C; Thelen K; Willmann S; Selen A; Dressman JB
J Pharm Sci; 2013 Sep; 102(9):3205-19. PubMed ID: 23696038
[TBL] [Abstract][Full Text] [Related]
31. Effect of hesperidin on the oral pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, in rats.
Cho YA; Choi DH; Choi JS
J Pharm Pharmacol; 2009 Jun; 61(6):825-9. PubMed ID: 19505375
[TBL] [Abstract][Full Text] [Related]
32. Separate Evaluation of Fraction Absorbed and Intestinal Availability after Oral Administration of Drugs Based on the Measurement of Portal and Systemic Plasma Concentrations and Luminal Concentration.
Tanaka Y; Ito K; Kurakazu T; Kasaoka S
Mol Pharm; 2023 Apr; 20(4):1933-1941. PubMed ID: 36914610
[TBL] [Abstract][Full Text] [Related]
33. In Situ Perfusion Model in Rat Colon for Drug Absorption Studies: Comparison with Small Intestine and Caco-2 Cell Model.
Lozoya-Agullo I; González-Álvarez I; González-Álvarez M; Merino-Sanjuán M; Bermejo M
J Pharm Sci; 2015 Sep; 104(9):3136-45. PubMed ID: 25891783
[TBL] [Abstract][Full Text] [Related]
34. Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability.
Lampen A; Christians U; Guengerich FP; Watkins PB; Kolars JC; Bader A; Gonschior AK; Dralle H; Hackbarth I; Sewing KF
Drug Metab Dispos; 1995 Dec; 23(12):1315-24. PubMed ID: 8689938
[TBL] [Abstract][Full Text] [Related]
35. Deacetylation of diltiazem by several rabbit tissues.
Fraile LJ; Aramayona JJ; Bregante MA; García MA; Abadía AR
Pharm Res; 1996 Dec; 13(12):1875-80. PubMed ID: 8987088
[TBL] [Abstract][Full Text] [Related]
36. Effects of morin pretreatment on the pharmacokinetics of diltiazem and its major metabolite, desacetyldiltiazem in rats.
Choi HJ; Choi JS
Arch Pharm Res; 2005 Aug; 28(8):970-6. PubMed ID: 16178425
[TBL] [Abstract][Full Text] [Related]
37. Systemic intestinal metabolism of 1-naphthol. A study in the isolated vascularly perfused rat small intestine.
de Vries MH; Hofman GA; Koster AS; Noordhoek J
Drug Metab Dispos; 1989; 17(5):573-8. PubMed ID: 2573503
[TBL] [Abstract][Full Text] [Related]
38. Absorption and metabolism of acetaminophen by the in situ perfused rat small intestine preparation.
Pang KS; Yuen V; Fayz S; te Koppele JM; Mulder GJ
Drug Metab Dispos; 1986; 14(1):102-11. PubMed ID: 2868852
[TBL] [Abstract][Full Text] [Related]
39. Cyclosporin C(2) and C(0) concentration monitoring in stable, long-term heart transplant recipients receiving metabolic inhibitors.
Ray JE; Keogh AM; McLachlan AJ; Akhlaghi F
J Heart Lung Transplant; 2003 Jul; 22(7):715-22. PubMed ID: 12873538
[TBL] [Abstract][Full Text] [Related]
40. Absorption of benzoic acid in segmental regions of the vascularly perfused rat small intestine preparation.
Cong D; Fong AK; Lee R; Pang KS
Drug Metab Dispos; 2001 Dec; 29(12):1539-47. PubMed ID: 11717172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
